General Healthcare

We recently met with Andrea Palmer, President of Publicis Health Media at the 2019 Cannes Lions Festival of Creativity. In this interview Andrea talks about the new generation of HCP and how the pharma industry can meet the changing consumer expectations, as well as her own career and leadership success.

We met with Isabel Torres, General Manager Finland, Takeda, at eyeforpharma Barcelona 2019 to talk about where the greatest opportunities lie in value-based healthcare, as well as initiatives that Isabel has been a part of, which really go beyond the medicine.

An interview with Thomas D’Hooghe, VP and Head Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany at this year’s eyeforpharma, Barcelona Conference. We speak to Thomas about advancements in the fields of fertility and assisted reproductive technology as well as pharma’s role in providing world-class endometriosis care to all.

An interview with John Zibert, Chief Medical Officer, Medical Director, LEO Innovation Lab at this year’s eyeforpharma, Barcelona Conference. We speak to John about the vision LEO Innovation Lab created for itself when it launched in 2015 and the potential of non-pharmaceutical based solutions in healthcare.

An interview with Kabir Nath, President and CEO, Otsuka North America at this year’s eyeforpharma, Barcelona conference. We speak to Kabir about Otsuka’s collaboration with Proteus Digital Health as well as the company’s unique set of values.

An interview with Roslyn Schneider, Former Global Patient Affairs Lead, Pfizer, at this year’s eyeforpharma, Barcelona conference.

An interview with Kasper Jerlang, Head of Global Digital Marketing and Engagement, LEO Pharma, at this year’s eyeforpharma, Barcelona conference. Kasper speaks about his role in digital marketing at LEO as well as the company culture and his approach to leadership.

An interview with Heather Moses, Head of Medical Affairs, Roche Products Ltd. We met with Heather at the Roche Hub, Welwyn Garden City, where Heather provided insight on the current and evolving landscape of Medical Affairs, as well as a personal perspective on senior leadership within the life-sciences industry.